BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14756144)

  • 1. Oxaliplatin.
    Graham J; Mushin M; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Jan; 3(1):11-2. PubMed ID: 14756144
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 4. A historical perspective on oxaliplatin: rethinking the role of platinum compounds and learning from near misses.
    Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):1-3. PubMed ID: 9609102
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.
    Field K; Zelenko A; Kosmider S; Court K; Ng LL; Hibbert M; Gibbs P
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):203-9. PubMed ID: 20887502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxaliplatin: perspectives and future developments].
    Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; EspiƩ M
    Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxaliplatin for the treatment of advanced colorectal cancer: future directions.
    Ducreux M; Louvet C; Bekradda M; Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):47-53. PubMed ID: 9609108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.
    Oncology (Williston Park); 2004 Sep; 18(10):1313. PubMed ID: 15526833
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of oxaliplatin: an active platinum agent in colorectal cancer.
    Cassidy J
    Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer.
    Becouarn Y; Rougier P
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):23-31. PubMed ID: 9609105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin in the treatment of colorectal cancer.
    Kim GP; Erlichman C
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of advanced colorectal cancer.
    O'Dwyer PJ; Stevenson JP
    Cancer Treat Res; 1998; 98():111-52. PubMed ID: 10326667
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 17. [ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms].
    Longo F; Mansueto G
    Tumori; 2005; 91(3):suppl 1-12. PubMed ID: 16206661
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Aug; 13(8):1116-8. PubMed ID: 10499245
    [No Abstract]   [Full Text] [Related]  

  • 19. Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.
    Siu SW; Chan WL; Liu KY; Choy TS; Leung TW; Au KH
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):558-9. PubMed ID: 21524570
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials referral resource. Clinical trials of single-agent oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Jul; 13(7):966, 969-70. PubMed ID: 10442343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.